⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

TRLV

Trulieve Cannabis Corp.

Healthcare · Drug Manufacturers - Specialty & Generic

10.42USD

-0.5000 (-4.58%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on TRLV.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 10.42
P/E—
Dvd Ind Yld0.0%
P/B2.62
P/S1.8
Curr EV/T12M EBITDA7.5
Mkt Cap (USD)2.0B
Curr EV (USD)2.3B
2)

Per Share Data

EPS T12M-2.47
DPS—
Bk Val Per Sh3.99
Rev/Sh5.91
Cash/Sh1.69
Curr Shares Out170.2M
FCF/Sh1.01
3)

Cash Flow Analysis

P/CF8.2
Curr P/FCF10.3
CF/NI-0.5
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales21.5%
Eff Interest Rate20.2%
4)

Growth Potential

Dil EPS 1Y Gr26.6%
Cap 1Y Gr-20.7%
BPS 1Y Gr-9.1%
R&D To Sales—
Retention Rate100.0%
Rev 1Y Gr-0.4%
FCF 1Y Gr53.6%
Assets 1Y Gr-6.1%
5)

Profitability

EBITDA-0.2B
EBIT-0.3B
Operating Margin-24.3%
Pretax Margin-28.6%
Net Margin-41.8%
ROA-19.0%
ROE-48.2%
ROC—
Asset Turnover0.46
6)

Structure

Current Ratio5.94
Quick Ratio3.71
Debt/Assets9.5%
Debt/Com Eq25.8%
Net Debt/EBITDA0.78
Tot Debt/Capital20.5%
Gross Margin59.5%
EBIT/Int Exp-4.9

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.